Example: Heart Attack

Search clinical trials for: Mitoxantrone

Total 304 results

NCT02043756

Completed

Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection

Conditions: Neoplasms
NCT04668690

Not yet recruiting

Clinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients With Relapsed/Refractory PTCL

Conditions: Peripheral T Cell Lymphoma
NCT02021825

Unknown status

Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders

Conditions: Neuromyelitis Optica; Neuromyelitis Optica Spectrum Disorders
NCT03839446

Recruiting

Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy

Conditions: Acute Myeloid Leukemia
NCT01842672

Recruiting

Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia

Conditions: Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia; Lymphoblastic Lymphoma; Diffuse Large B-cell Lymphoma; Burkitt Lymphoma/Leukemia
NCT02686593

Completed

Clofarabine, Cytarabine and Mitoxantrone (CLAM) for Relapsed or Refractory AML

Conditions: Acute Myeloid Leukemia
NCT03776279

Unknown status

A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma

Conditions: Relapsed or Refractory Peripheral T-cell and NK/T-cell Lymphoma
NCT02856685

Unknown status

A Study of Mitoxantrone Hydrochloride Liposome Infusion

Conditions: Non-Hodgkin's Lymphoma
NCT03258320

Recruiting

A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients Without Metastasis

Conditions: Prostate Cancer Patients
NCT02596373

Unknown status

A Study of Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast Cancer

Conditions: Advanced Recurrent or Metastatic Breast Cancer
NCT01627938

Unknown status

Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination

Conditions: Multiple Sclerosis
NCT00477087

Terminated

Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer

Conditions: Prostatic Neoplasms
NCT00268242

Terminated

Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia

Conditions: Leukemia
NCT01214317

Completed

Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis

Conditions: Multiple Sclerosis
NCT00003858

Withdrawn

Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence

Conditions: Prostate Cancer
NCT02131688

Unknown status

Phase I Study of Mitoxantrone Hydrochloride Liposome Injection

Conditions: Malignant Lymphoma
NCT02597387

Unknown status

Clinical Trial of Mitoxantrone HCL Liposome Injection in Patients With Relapsed DLBCL and PT/NKCLs

Conditions: Relapsed DLBCL and PT/NKCLs
NCT00661492

Completed

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)

Conditions: Androgen-independent Prostate Cancer
NCT00901927

Terminated

Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma

Conditions: Follicular Lymphoma
NCT00304291

Completed

A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)

Conditions: Neuromyelitis Optica; Myelitis, Transverse; Demyelinating Autoimmune Diseases, CNS; Autoimmune Diseases of the Nervous System
NCT04548700

Not yet recruiting

Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCL

Conditions: Treatment-naïve; Peripheral T Cell Lymphoma
NCT00146159

Terminated

Study Evaluating Mitoxantrone in Multiple Sclerosis

Conditions: Secondary Progressive Multiple Sclerosis
NCT00059631

Completed

Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone

Conditions: Prostate Cancer
NCT04509466

Not yet recruiting

Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL

Conditions: Extranodal NK/T-cell Lymphoma, Nasal Type
NCT00447473

Terminated

Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer

Conditions: Prostatic Neoplasms